Ex Parte 5855920 et al - Page 2




             Appeal No. 2005-2593                                                               2              
             Application No. 90/005,867                                                                        

                   The examiner relies on the following references:                                            
             Fahy     WO 95/32991    Dec. 7, 1995                                                              
             Umbreit    DE 43 26 948    Nov. 17,                                                               
                                                                              1994                             
             Robert O. Scow & Susie N. Hagan, Effect of Testosterone Propionate and Growth                     
             Hormone on Growth and Chemical Composition of Muscle and Other Tissues in                         
             Hypophysectomized Male Rats, 77 Endocrinology 852-57 (1965) (hereinafter “Scow”).                 
             Walter Pierpaoli & William Regelson, The Melatonin Miracle, Nature’s Age-Reversing                
             Disease Fighting Sex-Enhancing Hormone 259-75 (Pocket Books 1995) (hereinafter                    
             “Pierpaoli”).                                                                                     
                   The following rejections are at issue in this appeal:                                       
                   (1) Claims 1, 2, 7, 8, 10 and 11 are rejected under 35 U.S.C. § 102(b) as                   
             being anticipated by Fahy.                                                                        
                   (2) Claims 1, 2, 4-8, 10, 11, 13-17 and 25-36 are rejected under 35 U.S.C. §                
             103 as being unpatentable over the combined teachings of Fahy, Scow, Umbreit and                  
             Pierpaoli.                                                                                        
                                                  Discussion                                                   
                   A.     Rejection of claims 1, 2, 7 and 8 under 35 U.S.C. § 102(b)                           
                   Claims 1, 2, 7 and 8 are rejected under 35 U.S.C. § 102(b) as being anticipated             
             by Fahy.  Claim 1 is directed to a hormone replenishment method and reads as follows:             
                          1.  A hormone replenishment method comprising:                                       
                          measuring hormone levels in a sample of an otherwise healthy                         
                   human subject’s blood to determine that the level of human growth                           
                   hormone and the supplemental hormones selected from the group                               
                   consisting of sex hormone, melatonin hormone, adrenal hormone, thyroid                      
                   hormone, and thymus hormone are below pre-determined physiological                          
                   levels for an adult human; and                                                              
                          replenishing said level of said deficient hormones to pre-determined                 
                   physiological levels.                                                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007